Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Gordon

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Alzheimer'S Research & Therapy|May 21, 2022
Correction to: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibodyChad J Swanson, Yong Zhang, Shobha Dhadda, et al.
Alzheimer'S Research & Therapy|April 18, 2021
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibodyChad J Swanson, Yong Zhang, Shobha Dhadda, et al.
JMIR Research Protocols|August 25, 2022
Continuous Remote Patient Monitoring in Patients With Heart Failure (Cascade Study): Protocol for a Mixed Methods Feasibility StudyCourtney Reamer, Wei Ning Chi, Robert Gordon, et al.
Nature Ecology & Evolution|June 13, 2023
Research codes and contracts do not guarantee equitable research with Indigenous communitiesStasja Koot, Julie Grant, Moses /Khumûb, et al.
Biomaterials Advances|December 2, 2024
The effect of osteoclasts on epigenetic regulation by long non-coding RNAs in osteoblasts grown on titanium with nanotopographyRayana Longo Bighetti-Trevisan, Luciana Oliveira Almeida, Jaqueline Isadora Reis Ramos, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2002
Discovery of a potent and selective COX-2 inhibitor in the alkoxy lactone series with optimized metabolic profileYves Leblanc, Patrick Roy, Zhaoyin Wang, et al.
Comprehensive Psychiatry|January 29, 2023
Feasibility, acceptability and practicality of transcranial stimulation in obsessive compulsive symptoms (FEATSOCS): A randomised controlled crossover trialNaomi A Fineberg, Eduardo Cinosi, Megan V A Smith, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Comparison between two classes of selective EP(3) antagonists and their biological activitiesMichel Belley, Chi Chung Chan, Yves Gareau, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Structure-activity relationship studies on ortho-substituted cinnamic acids, a new class of selective EP(3) antagonistsMichel Belley, Michel Gallant, Bruno Roy, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 15, 2018
Early immune biomarkers and intermediate-term outcomes after heart transplantation: Results of Clinical Trials in Organ Transplantation-18Josef Stehlik, Brian Armstrong, David A Baran, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Alzheimer'S Research & Therapy|May 21, 2022
Correction to: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibodyChad J Swanson, Yong Zhang, Shobha Dhadda, et al.
Alzheimer'S Research & Therapy|April 18, 2021
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibodyChad J Swanson, Yong Zhang, Shobha Dhadda, et al.
JMIR Research Protocols|August 25, 2022
Continuous Remote Patient Monitoring in Patients With Heart Failure (Cascade Study): Protocol for a Mixed Methods Feasibility StudyCourtney Reamer, Wei Ning Chi, Robert Gordon, et al.
Nature Ecology & Evolution|June 13, 2023
Research codes and contracts do not guarantee equitable research with Indigenous communitiesStasja Koot, Julie Grant, Moses /Khumûb, et al.
Biomaterials Advances|December 2, 2024
The effect of osteoclasts on epigenetic regulation by long non-coding RNAs in osteoblasts grown on titanium with nanotopographyRayana Longo Bighetti-Trevisan, Luciana Oliveira Almeida, Jaqueline Isadora Reis Ramos, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2002
Discovery of a potent and selective COX-2 inhibitor in the alkoxy lactone series with optimized metabolic profileYves Leblanc, Patrick Roy, Zhaoyin Wang, et al.
Comprehensive Psychiatry|January 29, 2023
Feasibility, acceptability and practicality of transcranial stimulation in obsessive compulsive symptoms (FEATSOCS): A randomised controlled crossover trialNaomi A Fineberg, Eduardo Cinosi, Megan V A Smith, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Comparison between two classes of selective EP(3) antagonists and their biological activitiesMichel Belley, Chi Chung Chan, Yves Gareau, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Structure-activity relationship studies on ortho-substituted cinnamic acids, a new class of selective EP(3) antagonistsMichel Belley, Michel Gallant, Bruno Roy, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 15, 2018
Early immune biomarkers and intermediate-term outcomes after heart transplantation: Results of Clinical Trials in Organ Transplantation-18Josef Stehlik, Brian Armstrong, David A Baran, et al.
Pageof 12